Guangzhou LintonPharm Co.,Ltd.

Research - Guangzhou, Guangdong, China

Guangzhou LintonPharm Co.,Ltd. Employees

Dongchen Li

Director Of Business Development

Contact All Guangzhou LintonPharm Co.,Ltd. Employees

Guangzhou LintonPharm Co.,Ltd. Details

LintonPharm Co., Ltd. is a clinical-stage, research-oriented biopharmaceutical company committed to developing innovative T cell engaging bispecific antibodies with the goal of turning malignant cancers into manageable and possibly curable diseases. The company's lead development program is with catumaxomab, a clinically validated bispecific antibody which was the first approved T-cell engager, and its associated Triomab technology platform. LintonPharm, in collaboration with Lindis Biotech, is also developing a next generation bispecific antibody platform known as Fleximab which aims to provide better CMC developability and less immunogenicity. The LintonPharm pipeline includes several treatments in development for blood cancer and solid tumors that use the Triomab and Fleximab platforms. For more information, please visit www.lintonpharm.com.

Website: http://www.lintonpharm.com

Employees: 8

HQ:

Location: Guangzhou, Guangdong, China

Revenue:

Guangzhou LintonPharm Co.,Ltd. Technologies

Load Balancers

Nginx

View All Technologies Used At Guangzhou LintonPharm Co.,Ltd.

Similar companies to Guangzhou LintonPharm Co.,Ltd.

4B Technologies, Ltd PKU Advanced Financial Information Research Center Kongtum Co., Ltd. IEEE Transactions on Circuits and Systems I Jiangsu Boli Bioproducts Co., Ltd. SIYO BIOTECH Metanotitia Inc. LIDE Biotech ZYC Global Co.,Ltd Tongji-MIT City Science Lab Shanghai LePure Biotech Co., Ltd. 300 Forever Young Inc. Demand Chain Institute of Shanghai University Plenum China Research Chengdu Alfa Biotechnology Co.,Ltd D3 Bio TenNor Therapeutics Ludong University Kavli Institute for Theoretical Sciences, UCAS Hangzhou Go Top Peptide Biotech Co.,Ltd.